MBX Biosciences Common Stock Current Cash

MBX Biosciences Common Stock (MBX) currently reports a current cash of $54M as of June 2026. That compares with $40M in the prior-year period — up 36.1% year over year. Use the charts on this page to explore MBX Biosciences Common Stock's current cash history and peer comparisons.

MBX Biosciences Common Stock's current cash increased from $40M to $54M — a 36.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

MBX Biosciences Common Stock reported $54M in current cash as of June 2026. That compares with $40M in the prior-year period — up 36.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $54M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for MBX Biosciences Common Stock, and consider following MBX for alerts when major investors trade the stock.

MBX Biosciences Common Stock is classified in the Healthcare sector. On current cash, it currently shows $54M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MBX with unrelated industries.